Masami Iijima
CIK: 0002114485
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)1 (50.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAK
TAKEDA PHARMACEUTICAL CO LTD
Director
Discretionary Trading P&L
Holdings
About Iijima Masami
Iijima Masami (SEC CIK 0002114485) files insider reports with the SEC as Director of TAKEDA PHARMACEUTICAL CO LTD (TAK).
Signal8 holds 2 ownership filings by Iijima Masami (1 Form 3, 1 Form 4), filed between Mar 18, 2026 and Jul 6, 2026. Those filings report 2 transactions, from Jul 1, 2026 to Jul 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Iijima Masami's filings is in TOKYO.
Recent filings by Iijima Masami
Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Duprey Lauren Rusckowski, Chief Transformation Officer
- Plump Andrew Stewart, President, R&D
- Greenway Nicola Deidre Petal, Chief Human Resources Officer
- Farajallah Awny Samaan Botros, Chief Medical Officer
- Ibrahim Ramy Riad Ahmed, President, PDT BU
- Pacheco Rhonda Janice, President, U.S. Business Unit